Formosa Optical Technology Co.,Ltd. (TPEX:5312)
143.50
+3.00 (2.14%)
May 13, 2025, 1:30 PM CST
TPEX:5312 Revenue
Formosa Optical Technology had revenue of 1.00B TWD in the quarter ending March 31, 2025, a decrease of -2.20%. This brings the company's revenue in the last twelve months to 3.95B, up 0.87% year-over-year. In the year 2024, Formosa Optical Technology had annual revenue of 3.97B with 2.80% growth.
Revenue (ttm)
3.95B
Revenue Growth
+0.87%
P/S Ratio
2.17
Revenue / Employee
n/a
Employees
n/a
Market Cap
8.62B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.97B | 108.21M | 2.80% |
Dec 31, 2023 | 3.86B | 565.98M | 17.16% |
Dec 31, 2022 | 3.30B | 384.55M | 13.20% |
Dec 31, 2021 | 2.91B | -148.72M | -4.86% |
Dec 31, 2020 | 3.06B | -154.27M | -4.80% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 11.34B |
Caliway Biopharmaceuticals | 40.47M |
Bora Pharmaceuticals Co., LTD. | 19.25B |
Lotus Pharmaceutical | 19.12B |
Polaris Group | 107.00M |
Oneness Biotech | 117.93M |
Pegavision | 6.69B |
Lumosa Therapeutics | 43.59M |